R Carpenter

Summary

Affiliation: Barts and The London NHS Trust
Country: UK

Publications

  1. ncbi Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen
    R Carpenter
    St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Eur J Surg Oncol 34:746-55. 2008
  2. ncbi Modulation of very late activation-2 laminin receptor function in breast cancer metastasis
    G P Gui
    Department of Surgery, St Bartholomew s Hospital, London, UK
    Surgery 118:245-50. 1995
  3. ncbi The role of radiotherapy in treating small early invasive breast cancer
    P Varghese
    Breast Unit, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    Eur J Surg Oncol 34:369-76. 2008
  4. ncbi 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection
    L Biassoni
    Department of Nuclear Medicine and Research Laboratory, St Bartholomew s Hospital, The Royal Hospitals NHS Trust, London, UK
    Br J Cancer 77:131-8. 1998
  5. ncbi Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
    M Bhattacharyya
    Department of Medical Oncology, St Bartholomew s Hospital, West Smithfield, London EC1M 7BE, UK
    Br J Cancer 98:289-93. 2008
  6. ncbi Altered cell-matrix contact: a prerequisite for breast cancer metastasis?
    G P Gui
    Department of Surgery, St Bartholomew s Hospital, West Smithfield, London, UK
    Br J Cancer 75:623-33. 1997
  7. ncbi Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer
    P Varghese
    Breast Unit, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    Eur J Surg Oncol 33:147-52. 2007
  8. ncbi Role of aromatase inhibitors in breast cancer
    R Carpenter
    The Breast and Endocrine Unit, St Bartholomew s Hospital, London EC1A 7BE, UK
    Br J Cancer 93:S1-5. 2005
  9. ncbi Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies
    A D Jenkinson
    The Breast Surgery Unit, St Bartholomew s Hospital, The Royal Hospitals NHS Trust, West Smithfield, London EC1A 7BE, UK
    Eur J Surg Oncol 27:21-5. 2001
  10. ncbi Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer
    K McCarthy
    Breast Unit, St Bartholomew's Hospital, Barts and the London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    Eur J Surg Oncol 32:707-9. 2006

Collaborators

Detail Information

Publications18

  1. ncbi Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen
    R Carpenter
    St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Eur J Surg Oncol 34:746-55. 2008
    ....
  2. ncbi Modulation of very late activation-2 laminin receptor function in breast cancer metastasis
    G P Gui
    Department of Surgery, St Bartholomew s Hospital, London, UK
    Surgery 118:245-50. 1995
    ..001). CONCLUSIONS. VLA-2-mediated adhesion of primary breast cancer cells to laminin differs with nodal status. Measurement of VLA-2 expression may thus be of clinical value as a prognostic indicator in the assessment of breast cancer...
  3. ncbi The role of radiotherapy in treating small early invasive breast cancer
    P Varghese
    Breast Unit, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    Eur J Surg Oncol 34:369-76. 2008
    ..The aim of the study was to identify if radiotherapy can be safely avoided in a selected subgroup of largely screening detected small invasive breast cancer...
  4. ncbi 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection
    L Biassoni
    Department of Nuclear Medicine and Research Laboratory, St Bartholomew s Hospital, The Royal Hospitals NHS Trust, London, UK
    Br J Cancer 77:131-8. 1998
    ..Sensitivity was 90% (nine out of ten), specificity 84% (16 out of 19) and accuracy 86%. These results encourage further assessment of this technique...
  5. ncbi Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
    M Bhattacharyya
    Department of Medical Oncology, St Bartholomew s Hospital, West Smithfield, London EC1M 7BE, UK
    Br J Cancer 98:289-93. 2008
    ....
  6. ncbi Altered cell-matrix contact: a prerequisite for breast cancer metastasis?
    G P Gui
    Department of Surgery, St Bartholomew s Hospital, West Smithfield, London, UK
    Br J Cancer 75:623-33. 1997
    ..This study demonstrates a link between altered integrin expression and function in primary breast cancers predisposed to metastasize...
  7. ncbi Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer
    P Varghese
    Breast Unit, St Bartholomew s Hospital, Queen Mary University of London, London, UK
    Eur J Surg Oncol 33:147-52. 2007
    ..The study compared the accuracy and success rate of two techniques, methylene blue alone versus combined methylene blue and radioactive colloid in sentinel lymph node localisation in the management early breast cancer...
  8. ncbi Role of aromatase inhibitors in breast cancer
    R Carpenter
    The Breast and Endocrine Unit, St Bartholomew s Hospital, London EC1A 7BE, UK
    Br J Cancer 93:S1-5. 2005
    ..This paper provides an overview of the current and future roles of aromatase inhibitors for breast cancer treatment...
  9. ncbi Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies
    A D Jenkinson
    The Breast Surgery Unit, St Bartholomew s Hospital, The Royal Hospitals NHS Trust, West Smithfield, London EC1A 7BE, UK
    Eur J Surg Oncol 27:21-5. 2001
    ..Patients with invasive ductal carcinomas are more likely to benefit from breast conserving surgery that is tailored to include the associated ductal tissue, in a segmental fashioned excision...
  10. ncbi Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer
    K McCarthy
    Breast Unit, St Bartholomew's Hospital, Barts and the London Queen Mary School of Medicine and Dentistry, West Smithfield, London EC1A 7EA, UK
    Eur J Surg Oncol 32:707-9. 2006
    ..There was no correlation between COX-2 mRNA levels and tumour size, grade, nodal status and presence of vascular invasion. CONCLUSIONS: COX-2 mRNA expression is increased in oestrogen and progesterone receptor negative breast cancers...
  11. ncbi Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1
    A R Al Yasi
    Department of Nuclear Medicine, St Bartholomew s Hospital, London EC1A 7BE, UK
    Br J Cancer 86:870-8. 2002
    ..A specificity of 93% and positive predictive value of 92% (both 100% if a second cancer in the axilla with negative nodes is considered) were found. A strategy for combining negative imaging with the sentinel node procedure is presented...
  12. ncbi Is radiotherapy needed after breast conservation for small invasive breast cancers?
    A C Athow
    St Bartholomew's Hospital, West Smithfield, London, UK
    Eur J Surg Oncol 28:379-82. 2002
    ..Further follow-up is required to substantiate this...
  13. ncbi Integrin expression and survival in human breast cancer
    M G Berry
    Department of Academic Surgery, St Bartholomew's and The Royal London Hospitals School of Medicine and Dentistry, London, UK
    Eur J Surg Oncol 30:484-9. 2004
    ..Despite proven molecular importance in tumour cell adhesion, invasion and metastasis, integrin expression would appear not to translate clinically as independent indicators of prognosis, at least in the short-term...
  14. ncbi How significant is detection of ductal carcinoma in situ in a breast screening programme?
    P Kessar
    Department of Radiology, St Bartholomew's Hospital, London, UK
    Clin Radiol 57:807-14. 2002
    ..Mammographic patterns are not always reliable in the prediction of tumour grade. The detection of DCIS in screening programmes is important and should not be regarded as over-diagnosis...
  15. ncbi EJSO 2001; 27:218-9
    A Mostafa
    Eur J Surg Oncol 28:462. 2002
  16. ncbi Estimating the benefits of adjuvant systemic therapy for women with early breast cancer
    K McCarthy
    Br J Surg 89:496. 2002
  17. ncbi Angiosarcoma of the breast after wide local excision and radiotherapy for breast carcinoma
    T D Mills
    St Bartholomew's Hospital, London, UK
    Clin Radiol 57:63-6. 2002
  18. ncbi Infiltrating fibromatosis of the breast: a potential pitfall
    C Kouriefs
    Breast Unit, St Bartholomew's Hospital, London, UK
    Int J Clin Pract 56:401-2. 2002
    ..It presents a big dilemma for the clinician, because it mimics breast cancer clinically, radiologically and sometimes cytologically. We report a case of fibromatosis of the breast and highlight the diagnostic difficulties and management...